Sanofi ready to raise bid if Genzyme talks: report
by on Sep.05, 2010, under Health and Fitness
French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a person familiar with the matter.
View full post on Yahoo! Health News
